Skip to content
Assyro AI
FDA Orange Book · active-ingredient family

Etidronate disodium

Etidronate disodium: 2 brands, 1 generic; first approved Apr 20, 1987; generic available.

Generic availableHas discontinued products
Generic status & protection

Generic available: 1 ANDA application approved.

Brands (NDA)
2
Generics (ANDA)
1
Listed patents
0
Presentations
5

Brand (NDA) products

Originator applications
  • NDA 0178312 strengths
    Approved strengths under this FDA application.
    StrengthDosage formRouteStatusTE
    200MGTABLETORALDiscontinued
    400MGTABLETORALDiscontinued
  • NDA 0195451987
    Approved strengths under this FDA application.
    StrengthDosage formRouteStatusTE
    50MG/MLINJECTABLEINJECTIONDiscontinued

Generic (ANDA) products (1)

Abbreviated applications
  • ETIDRONATE DISODIUM
    ANDA 07580020032 strengths
    Approved strengths under this FDA application.
    StrengthDosage formRouteStatusTE
    200MGTABLETORALDiscontinued
    400MGTABLETORALDiscontinued

Listed patents

Orange Book patent file

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Approval history

FDA approval span
First approval
39 yr 11 mo ago
Most recent approval
23 yr 11 mo ago

Approvals span 1987–2003 across 3 FDA applications.

Brand (NDA) 267%
Generic (ANDA) 133%

Etidronate disodium: frequently asked questions

Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

Built directly from the FDA Orange Book data file (products, patents, and exclusivity). TE codes, RLD/RS flags, patent expirations, and exclusivity dates match the official FDA record. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Related FDA reference tools

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.